EP4331604
MÓTEFNI GEGN PD-L1 OG NOTKUN ÞEIRRA TIL AÐ ÖRVA VIRKNI T-FRUMA
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
8.12.2009EP published:
5.3.2025EP application number:
23214687.8
EP translation filed:
19.3.2025Grant published:
15.4.2025EPO information:
European Patent Register
Max expiry date:
7.12.2029Expiry date:
7.12.2026Next due date:
31.12.2026
Title in English:
ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTIONLanguage of the patent:
English
Timeline
Today
8.12.2009EP application
5.3.2025EP Publication
19.3.2025Translation submitted
15.4.2025Registration published
7.12.2026Expires
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
IRVING, BryanAddress:
San Francisco, 94107, US
Name:
CHEUNG, JeanneAddress:
San Francisco, 94158, US
Name:
CHIU, HenryAddress:
San Francisco, 94116, US
Name:
LEHAR, SophieAddress:
Montara, 94037, US
Name:
MAECKER, HeatherAddress:
South San Francisco, 94080-4990, US
Name:
MARIATHASAN, SanjeevAddress:
Millbrae, 94030, US
Name:
WU, YanAddress:
Foster City, 94404, US
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221, Hafnarfirði,
Priority
Number:
121092 PDate:
9.12.2008Country:
US
Supplementary protection
SPC number:
SPC516
Classification
Categories:
C07K 16/28, A61P 35/00, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 9.12.2025
Expires: 7.12.2026
Payer: Árnason Faktor ehf.